Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;36(4):e14580.
doi: 10.1111/ctr.14580. Epub 2022 Jan 15.

Immunosuppression in patients with grade 3 acute-on-chronic liver failure at transplantation: A practice analysis study

Francois Faitot  1   2 , Thierry Artzner  3 , Baptiste Michard  1 , Camille Besch  1 , Maleka Schenck  3 , Jean-Etienne Herbrecht  3 , Ralf Janssen Langenstein  3 , Quentin Maestraggi  3 , Max Guillot  3 , Marie-Line Harlay  3 , Vincent Castelain  3   4 , Pietro Addeo  1 , Bernard Ellero  1 , Marie-Lorraine Woehl-Jaegle  1 , Lawrence Serfaty  5 , Philippe Bachellier  1 , Francis Schneider  3   4 ; Strasbourg LIVER Transplantation (SLIVERT) Study group
Affiliations

Immunosuppression in patients with grade 3 acute-on-chronic liver failure at transplantation: A practice analysis study

Francois Faitot et al. Clin Transplant. 2022 Apr.

Abstract

Transplantation for patients with acute-on-chronic liver failure grade 3 (ACLF3) has encouraging results with 1-year-survival of 80-90%. These patients with multiple organ failure meet the conditions for serious alterations of drug metabolism and increased toxicity. The goal of this study was to identify immunosuppression-dependent factors that affect survival. This retrospective monocentric study was conducted in patients with ACLF3 consecutively transplanted between 2007 and 2019. The primary endpoint was 1-year survival. Secondary endpoints were overall survival, treated rejection, and surgical complications. Immunosuppression was evaluated as to type of immunosuppression, post-transplant introduction timing, trough levels, and trough level intra-patient variability (IPV). One hundred patients were included. Tacrolimus IPV < 40% (P = .019), absence of early tacrolimus overdose (P = .033), use of anti-IL2-receptor antibodies (P = .034), and early mycophenolic acid introduction (P = .038) predicted 1-year survival. Treated rejection was an independent predictor of survival (P = .001; HR 4.2 (CI 95%: 1.13-15.6)). Early everolimus introduction was neither associated with higher rejection rates nor with more surgical complications. Management of immunosuppression in ACLF3 critically ill patients undergoing liver transplantation is challenging. Occurrence and treatment of rejection impacts on survival. Early introduction of mTOR inhibitor seems safe and efficient in this situation.

Keywords: basilliximab; critically ill patients; everolimus; mycophenolic acid; rejection.

PubMed Disclaimer

References

REFERENCES

    1. Sundaram V, Mahmud N, Perricone G, et al. Multi-Organ Dysfunction, Evaluation for Liver Transplantation (MODEL) Consortium. Longterm Outcomes of Patients Undergoing Liver Transplantation for Acute-on-Chronic Liver Failure. Liver Transpl. 2020;26(12):1594-1602.
    1. O'Leary JG, Bajaj JS, Tandon P, et al. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: the Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience. Liver Transpl. 2019;25(4):571-579.
    1. Artru F, Louvet A, Ruiz I, et al. Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3. J Hepatol. 2017;67(4):708-715.
    1. Karvellas CJ, Lescot T, Goldberg P, et al. Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study. Crit Care. 2013;17(1):R28.
    1. Michard B, Artzner T, Lebas B, et al. Liver transplantation in critically ill patients : preoperative predictive factors of post-transplant mortality to avoid futility. Clin Transplant. 2017. https://doi.org/10.1111/ctr.13115.

MeSH terms

LinkOut - more resources